Cita APA

Turiello, R., Capone, M., Giannarelli, D., Morretta, E., Monti, M. C., Madonna, G., . . . Ascierto, P. A. (2020). Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy. J Immunother Cancer.

Chicago Style Citation

Turiello, Roberta, et al. "Serum CD73 Is a Prognostic Factor in Patients With Metastatic Melanoma and Is Associated With Response to Anti-PD-1 Therapy." J Immunother Cancer 2020.

Cita MLA

Turiello, Roberta, et al. "Serum CD73 Is a Prognostic Factor in Patients With Metastatic Melanoma and Is Associated With Response to Anti-PD-1 Therapy." J Immunother Cancer 2020.